Impact of "Telecoaching Program" on Physical Activity in Patients With COPD
MrPAPP
A 3-month Multicenter Randomized Trial to Evaluate the Efficacy of a Physical Activity Promotion Program on the Experience of Physical Activity in Patients With COPD (Mr PAPP)
1 other identifier
interventional
370
5 countries
6
Brief Summary
The purpose of this 3 month randomized intervention study is to investigate the additional effect of a physical activity telecoaching program on physical activity in patients with COPD, compared with usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2014
Shorter than P25 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 5, 2014
CompletedFirst Posted
Study publicly available on registry
June 6, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedMay 1, 2015
April 1, 2015
10 months
June 5, 2014
April 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Daily number of steps
The daily number of steps will be measured by the PROactive monitors (ActiGraph® and DynaPort®) at baseline (during the week prior to baseline visit) and at the end of the 3-month epoch (during the week prior to end visit).
changes from baseline to 3 months
Secondary Outcomes (5)
Time spent in at least moderate physical activity
changes from baseline to 3 months
Proportion of patients showing an increase of physical activity by >20%
changes from baseline to 3 months
6-minute walking test
changes from baseline to 3 months
isometric Quadriceps force
changes from baseline to 3 months
COPD symptoms and health-related quality of life
changes form baseline to 3 months
Other Outcomes (3)
daily and clinic visit version of PROactive instrument
changes from baseline to 3 months
Satisfaction with the telecoaching program
Information gathered after 3 months of intervention
Compliance with the telecoaching program
Information gathered after 3 months of intervention
Study Arms (2)
Usual care
NO INTERVENTIONPatients will receive information (leaflet) and guidance on the benefits associated with increased physical activity in COPD patients and their health status
Coaching program
EXPERIMENTALIn addition to usual care, patients will receive the coaching program
Interventions
The coaching program consists of a (1) Step counter used as a coaching activity monitor to collect number of steps walked by the patients and (2) the Linkcare System, a mobile phone or tablet PC placed in the patient's home to collect data from the step counter. The system will set a daily activity goal for the patient based on achieved activity levels which will be measured by the step counter. Patients will also receive feedback, motivational and educational messages and direct calls from the coaching team at each institution.
Eligibility Criteria
You may qualify if:
- Written informed consent must be obtained before any assessment is performed
- Male and female patients ≥ 40 years of age
- Diagnosis of COPD (GOLD criteria: post bronchodilator FEV1/FVC\< 70%)
- Current or ex-smokers with a smoking history equivalent to at least 10 pack years
- Patient should have at least 4 days of physical activity data recorded via PROactive monitors during 7 days prior to the baseline measurement
You may not qualify if:
- Orthopedic, neurological or other complaints that significantly impair normal biomechanical movement patterns, as judged by the investigator. Specifically if the patients' condition/ co-morbidities are such that physical activity cannot be increased, then they should not be enrolled
- Respiratory diseases other than COPD (e.g. asthma)
- Cognitive reading impairment and/or difficulties to manage electronic devices precluding interaction with the smartphone and PDA, as judged by the investigator
- Participating in or scheduled to start an outpatient rehabilitation program during the study. If the patient wishes to participate in pulmonary rehabilitation for any reason the patient can be enrolled in the study only at the end of rehabilitation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
- University of Edinburghcollaborator
- Royal Brompton & Harefield NHS Foundation Trustcollaborator
- University Medical Center Groningencollaborator
- University of Athenscollaborator
- University of Zurichcollaborator
- Barcelona Institute for Global Healthcollaborator
Study Sites (6)
KULeuven
Leuven, 3000, Belgium
Thorax Research Foundation
Athens, Greece
University Medical Center
Groningen, Netherlands
University of Zurich
Zurich, Switzerland
University of Edinburgh
Edinburgh, United Kingdom
Royal Brompton Hospital, Imperial College
London, United Kingdom
Related Publications (2)
Loeckx M, Rabinovich RA, Demeyer H, Louvaris Z, Tanner R, Rubio N, Frei A, De Jong C, Gimeno-Santos E, Rodrigues FM, Buttery SC, Hopkinson NS, Busching G, Strassmann A, Serra I, Vogiatzis I, Garcia-Aymerich J, Polkey MI, Troosters T. Smartphone-Based Physical Activity Telecoaching in Chronic Obstructive Pulmonary Disease: Mixed-Methods Study on Patient Experiences and Lessons for Implementation. JMIR Mhealth Uhealth. 2018 Dec 21;6(12):e200. doi: 10.2196/mhealth.9774.
PMID: 30578215DERIVEDDemeyer H, Louvaris Z, Frei A, Rabinovich RA, de Jong C, Gimeno-Santos E, Loeckx M, Buttery SC, Rubio N, Van der Molen T, Hopkinson NS, Vogiatzis I, Puhan MA, Garcia-Aymerich J, Polkey MI, Troosters T; Mr Papp PROactive study group and the PROactive consortium. Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial. Thorax. 2017 May;72(5):415-423. doi: 10.1136/thoraxjnl-2016-209026. Epub 2017 Jan 30.
PMID: 28137918DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Thierry Troosters, PT, PHD
KU Leuven
- STUDY CHAIR
Mike Polkey, MD, PHD
Royal Brompton & Harefield NHS Foundation Trust
- STUDY CHAIR
Judith Garcia-Aymerich, MD, PHD
Barcelona Institute for Global Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
June 5, 2014
First Posted
June 6, 2014
Study Start
May 1, 2014
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
May 1, 2015
Record last verified: 2015-04